Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Fa-Da Wang, Jing Zhou, En‐Qiang Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 86
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7873-7873
Open Access | Times Cited: 17
A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis
Marjia Sultana, Md Asrarul Islam, Rhema Khairnar, et al.
Molecular and Cellular Endocrinology (2025), pp. 112448-112448
Closed Access | Times Cited: 3
Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases
Junyan Zhu, Sicong Wang, Dakai Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Structural characteristics of a novel Bletilla striata polysaccharide and its activities for the alleviation of liver fibrosis
Guanghui Jiang, Bulei Wang, Yuwen Wang, et al.
Carbohydrate Polymers (2023) Vol. 313, pp. 120781-120781
Closed Access | Times Cited: 29
Programmed cell death in hepatic fibrosis: current and perspectives
Ju-Lu Lu, Chuan-Xin Yu, Li-Jun Song
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 28
Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents
Lin Chen, Wenyan Guo, Chun Mao, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 6, pp. 1446-1466
Closed Access | Times Cited: 14
Liver Fibrosis: From Basic Science to Clinical Progress
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
(2024)
Open Access | Times Cited: 8
Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Le Li, Zhijun Zhu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 15
Diagnosis of Liver Fibrosis Using Artificial Intelligence: A Systematic Review
Stefan‐Lucian Popa, Abdulrahman Ismaiel, Ludovico Abenavoli, et al.
Medicina (2023) Vol. 59, Iss. 5, pp. 992-992
Open Access | Times Cited: 14
Antagonizing the irreversible thrombomodulin-initiated proteolytic signaling alleviates age-related liver fibrosis via senescent cell killing
Christopher C. Pan, Raquel Maeso‐Díaz, Tylor R. Lewis, et al.
Cell Research (2023) Vol. 33, Iss. 7, pp. 516-532
Closed Access | Times Cited: 13
Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis
Diren Beyoğlu, Pinzhu Huang, Disha Skelton-Badlani, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 485-485
Open Access | Times Cited: 10
Challenges of in vitro modelling of liver fibrosis
Patricia Ros-Tárraga, Estela Villanueva-Bádenas, Estela Sanchez-Gonzalez, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis
Jiayin Chang, Congying Huang, Siqi Li, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 127-127
Open Access | Times Cited: 9
Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice
Qianyuan Gong, Zhao-Yu Zeng, Tao Jiang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 13
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities
Wei Chen, Yameng Sun, Shuyan Chen, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1118-1132
Open Access | Times Cited: 8
Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects
Xun Ye, Jinhu Li, Zibo Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113978-113978
Open Access | Times Cited: 12
Enzymes of Fibrosis in Chronic Liver Disease
Ioannis Tsomidis, George Notas, Costas Xidakis, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3179-3179
Open Access | Times Cited: 12
Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-β1/CUGBP1 and IFN-γ/Smad7 pathway
Linmao Ye, Jiaxin Huang, Xiaofan Liang, et al.
Phytomedicine (2024) Vol. 133, pp. 155916-155916
Closed Access | Times Cited: 2
The Metabolomic Footprint of Liver Fibrosis
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
Cells (2024) Vol. 13, Iss. 16, pp. 1333-1333
Open Access | Times Cited: 2
The Overlooked Impact of Cadmium on the Progression of Chronic Hepatitis and the Onset of Renal Failure in Advanced Cirrhosis
Ana Ćirović, Soisungwan Satarug, Jovan Jevtić, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127542-127542
Closed Access | Times Cited: 2
Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment
Hisham Qosa, Claudia H.M.C. De Oliveira, Giovanni Cizza, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1791-1802
Open Access | Times Cited: 6
Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions
Zanyar HajiEsmailPoor, Peyman Tabnak, Behnam Ahmadzadeh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113507-113507
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top